台湾swag

Licensing Opportunities

Licensing Opportunities

The 台湾swag 台湾swag aims to maximise the impact of its scientific discoveries; where appropriate this is achieved through commercialisation of its intellectual property rights. This primarily involves licensing new discoveries and technologies to pharma and biotech companies, but in some cases commercialisation is achieved through spinning-out new companies such as .

Current licensing opportunities

Using hPSCs as a source of human amnion-like cells provides a standardised, inexpensive and potentially unlimited source of amnion cells


This novel technology can simultaneously profile multiple histone modifications and transcriptomes, at single-cell resolution